Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes
Nanami SenooiD, Macie S. Sheridan, Yvonne WohlfarteriD, Mackenzie T. PrimroseiD, Emmanouil TampakakisiD, Markus Andreas KelleriD, Steven Michael ClaypooliD
Abstract
Barth syndrome, a rare X-linked genetic disorder, features early-onset cardiomyopathy. The causal gene, TAFAZZIN, encodes a transacylase that mediates acyl chain remodeling of cardiolipin, a critical phospholipid in the inner mitochondrial membrane. While Barth syndrome exhibits hallmark cardiolipin abnormalities, the precise mechanisms linking TAFAZZIN deficiency and disturbed cardiolipin metabolism to progressive cardiac dysfunction remain unclear. In this study, we modeled Barth syndrome cardiomyopathy in human induced pluripotent stem cell-derived cardiomyocytes with in vitro maturation treatments that simulate heart developmental stimuli. We found that cardiomyocyte maturation involves progressive cristae dynamics associated with protein and lipid alterations in the inner mitochondrial membrane. TAFAZZIN-deficient cardiomyocytes fail to adapt to the developmental stimuli, resulting in damaged cristae, compromised mitochondrial respiration, and cardiomyocyte dysfunction. These results demonstrate that TAFAZZIN deficiency perturbs functional and structural development of mitochondria, which may contribute to mitochondrial dysfunction and associated childhood progression to cardiomyopathy in Barth syndrome.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 8.32
- Field percentile
- top 2%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth Syndrome
Olivia Sniezek Carney, Kodi William Harris, … Hilary J. Vernon·Human Molecular GeneticsPeer-reviewed·Oct 29, 2024
- Targeting ALCAT1 Ameliorates Cardiomyopathy in Barth Syndrome
Jun Zhang, Qianqian Ye, … Yuguang Shi·bioRxiv·Sep 28, 2026
- Deficient Cardiolipin Remodeling Alters Muscle Fiber Composition and Neuromuscular Connectivity in Barth Syndrome
Catalina Matias, Paige L. Snider, … Jeffrey J. Brault·bioRxiv·Oct 31, 2025
- Barth syndrome cellular models have dysregulated respiratory chain complex I and mitochondrial quality control due to abnormal cardiolipin
Arianna Franca Anzmann, Olivia Sniezek Carney, … Hilary J. Vernon·bioRxiv·Jan 6, 2021
- Integrated Multi-Omics Mapping of Mitochondrial Dysfunction and Substrate Preference in Barth Syndrome Cardiac Tissue
Bauke V. Schomakers, Adriana S Passadouro, … Signe Mosegaard·EMBO Molecular MedicinePeer-reviewed·Oct 13, 2025
- Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn, … Itay Budin·Journal of Biological ChemistryPeer-reviewed·Jun 29, 2026